Argiles, GuillemAlbanell Mestres, JoanTabernero Cartula, Josep2019-02-282019-02-282017Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A. et al. LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun 1;28(Suppl 3):151. DOI: 10.1093/annonc/mdx302.0030923-7534http://hdl.handle.net/10230/36688application/pdfeng© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of oncology following peer review. The version of record [Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A. et al. LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun 1;28(suppl_3) is available online at: https://academic.oup.com/annonc/article/28/suppl_3/mdx302.003/3916891. DOI: 10.1093/annonc/mdx302.003Còlon -- Càncer -- Aspectes genèticsLBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)info:eu-repo/semantics/articlehttp://dx.doi.org/10.1093/annonc/mdx302.003info:eu-repo/semantics/openAccess